{
  "pmcid": "8514577",
  "sha256": "c7d0dff15c6d1e623c6c5233057f9ccad0c26ca32f8c119161dd088c6095d06b",
  "timestamp_utc": "2025-11-09T22:58:34.512448+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.244959834153924,
    "reading_ease": 9.546962943767852,
    "word_count": 227
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Intraoperative Methylprednisolone in Neonatal Cardiac Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Neonates undergoing cardiac surgery were randomized"
      },
      "Participants": {
        "score": 2,
        "evidence": "Neonates undergoing cardiac surgery"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized to receive either intraoperative methylprednisolone or placebo"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to determine if intraoperative methylprednisolone during neonatal cardiac surgery is associated with neurodevelopmental outcomes at 12 months of age."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was neurodevelopmental outcomes measured by the Bayley Scales of Infant and Toddler Development-III (BSID-III) at 12 months."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomization was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding included outcome assessors, patients, and clinicians."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 129 participants were randomized (61 to methylprednisolone, 68 to placebo)"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "analyzed using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Participants undergoing palliative procedures had lower cognitive (mean difference = -5, 95% CI -9 to -1, p=0.03) and motor scores (mean difference = -9, 95% CI -14 to -4, p<0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}